SpecificationsOrganism/cell line/tissue*Homo sapiens/hPSC line FS3F.2/Atrial and ventricular heart biopsies*Sex*Male*Sequencer or array type*HumanHT-12 v4*Data format*Raw and processed*Experimental factors*hPSC-derived CMs: untreated cells harvested at weekly intervals*Experimental features*hPSCs were differentiated into cardiomyocytes and maintained under adherent culture conditions in low fetal calf serum-containing media. Samples were taken at weekly intervals up to 8 weeks. Human atrial and ventricular biopsy samples served as in vivo reference.*Consent*Written informed consent was obtained from patients where applicable.*Sample source location*Münster, Germany*

Direct link to deposited data {#s0010}
=============================

Deposited data can be found here: <http://www.dtd.nlm.nih.gov/geo/query/acc.cgi?acc=GSE64189>.

Experimental Design, Materials and Methods {#s0015}
==========================================

Generation and processing of samples {#s0020}
------------------------------------

Cell culture. hPSCs, cell line FS3F.2 [@bb0005], were maintained in FTDA medium [@bb0010], on Matrigel™-coated dishes. Cardiac differentiation was induced as described [@bb0015]. In brief, fully confluent hPSC cultures were harvested using Accutase™ digestion, and replated onto Matrigel-coated 24-well plates (500,000 cells per well in 2 ml of day 0 differentiation medium). An aliquot of cells was used for RNA isolation (0 week time-point). Day 0 differentiation medium contained Knockout™ DMEM, insulin/transferrin/selenium, 10 μM Y27632, penicillin/streptomycin/[l]{.smallcaps}-Glutamine, 10 ng/ml FGF2, 1 ng/ml BMP4, and 1 μM CHIR99021 [@bb0015]. Day 1 medium contained Knockout™ DMEM transferrin/selenium penicillin/streptomycin/[l]{.smallcaps}-Glutamine, and 250 μM phospho-ascorbate (TS medium). On days 2 and 3, cells were fed with TS medium supplemented with 2 μM of WNT inhibitor IWP-2. Hence after, cells were maintained in basal TS medium. Spontaneous beating was observed from day 6 onwards. CM differentiation efficiency was above 85% as judged by FACS counting [@bb0015]. On day 7, the cells were harvested using 1 × TrypLE Select (Life Technologies), and pooled from independent samples. An aliquot of cells was used for RNA isolation (1 week time-point), and the remaining cells replated at \~ 250,000 cells per well of a Matrigel-coated 24-well plate, in 2% fetal calf serum/Knockout DMEM/penicillin/streptomycin/[l]{.smallcaps}-Glutamine. Thereafter, medium was replaced every 3--4 days. Samples of maturating hPSC-CMs were taken at weekly intervals up to 8 weeks, to be subjected to microarray analysis. Total RNA was isolated using Qiagen RNeasy columns with on-column DNA digestion.

Human heart samples. RNA samples from left and right atrial appendages have been previously described [@bb0020]. RNA samples were pooled from six independent patients per tissue type. The human left and right ventricular RNA samples were from a commercial supplier (Biocat \#R1234138‐50‐BC and \#R1234139‐50‐BC, respectively).

500 ng of total RNA from each biological sample was used as input for the generation of biotin-labeled cRNA using an Illumina® TotalPrep™ RNA amplification kit (Life Technologies). Following the manufacturer\'s instructions, in vitro transcription of double-stranded cDNA was performed for 14 h, in a PCR cycler. Purified biotin-labeled cRNA was eluted in a volume of 100 μl and quality-checked on a 2100 Bioanalyzer device (Agilent Technologies). cRNA samples were adjusted to 150 ng/μl in water, and hybridized onto Illumina HumanHT-12 v4 bead arrays following the manufacturer\'s instructions throughout. Hybridization was carried out at 58 °C for 18 h. Staining with streptavidin-Cy3 (GE Healthcare \#PA43001) was carried out as recommended, at a concentration 1 μg/ml in blocking buffer. Dried bead arrays were scanned on a HiScan SQ device (Illumina) using default settings.

Technical and biological data quality assessment {#s0025}
------------------------------------------------

Scanned images were confirmed to show an overall clean fluorescence spot morphology with high signal-to-noise ratio, and array data were confirmed to display an average P~95~ intensity of \> 800 (a.u.). Inspection of raw data in GenomeStudio suggested an overall high hybridization stringency, according to internal mismatch control probes, and no major hybridization artifacts. Following these routine checks, all separately hybridized samples were background-subtracted and normalized using the Cubic Spline algorithm in GenomeStudio. This revealed a high degree of similarity between the left/right human heart samples, suggesting that they could be combined in silico. To assess overall human heart-specific gene expression regardless of chamber-specific differences, data was additionally analyzed by combining all human atrial and ventricular samples using GenomeStudio software.

As a biological quality control step, known markers were used to assess differential gene expression between the distinct types of samples. In line with the expectations, hPSC-specific genes *OCT4*, *NANOG* and *SOX2* were only expressed in the undifferentiated (0 week) cells. Conversely, structural cardiac markers (*MYH6*, *MYL4*, *MYL7*) were indeed only expressed in the differentiated samples and not in the undifferentiated cells ([Fig. 1](#f0005){ref-type="fig"}A, left). Focusing on gene expression changes upon long-term in vitro culture, maturation markers such as *MYL2* and *MYH7* were upregulated in the late (8 weeks) samples, whereas markers of immature hPSC-CMs were indeed overrepresented in the early (1 week) samples ([Fig. 1](#f0005){ref-type="fig"}A, middle). As supported by functional assays [@bb0015], however, there were only marginal differences between 4 weeks and 8 week-old hPSC-CMs, suggesting that the cells reach a rather stable transcriptomic state from approximately 4 weeks onwards ([Fig. 1](#f0005){ref-type="fig"}A, right). Furthermore, the expression pattern of the pan-cardiac marker *ACTC1* (cardiac muscle alpha actin) served to indicate an overall stable cardiomyocyte signature in all differentiated samples (1 to 8 weeks, [Fig. 1](#f0005){ref-type="fig"}B).

Basic data analysis {#s0030}
-------------------

A comparison of human atrial and ventricular samples allowed for the identification of marker genes. Using stringent filtering criteria (\> 10-fold differences in gene expression), these included known structural genes, ion channels, as well as transcriptional regulators ([Fig. 2](#f0010){ref-type="fig"}, [Table 1](#t0005){ref-type="table"}). For instance, myosin light chain 2 (*MYL2*, also known as *MLC2v*) presents a rather stringent ventricular marker. By contrast, the frequently used *MYL7* (*MLC2a*) was only about 2-fold enriched in atrial tissue, suggesting that it does not well discriminate between human cardiac subtypes. Instead, the natriuretic peptide-encoding genes *NPPA* and *NPPB* are excellent atrial markers according to this analysis.

Analyzing the hPSC-based together with the in vivo data allows determination of shared and divergent gene expression between hPSC-CMs and human heart. In line with the expectations, scatter plot and clustering analyses between human heart versus (i) undifferentiated hPSCs, (ii) early (1 week) hPSC-CMs, and (iii) maturated hPSC-CMs (combined 4--8 weeks samples) suggest that over time, hPSC-CMs tend to become more similar to the human adult heart reference ([Fig. 3](#f0015){ref-type="fig"}). This tendency is also supported by the fact that a set of known immature CM markers (*NKX2.5*, *IRX4*, and others) declines upon long-term in vitro culture, whereas a set of maturation marker genes (MYH7, MYL2, and others) reached human heart-like expression levels over time (blue and orange colored genes, respectively, in [Fig. 3](#f0015){ref-type="fig"}). However, even in late hPSC-CMs a number of human heart genes were not expressed, and the global similarity to the in vivo reference appears to be rather limited (red colored genes in [Fig. 3](#f0015){ref-type="fig"}, [Table 2](#t0010){ref-type="table"}).

Discussion {#s0005}
==========

Despite the fact that neither the in vitro-derived nor the in vivo samples consisted of pure populations of cardiomyocytes, this data set suggests that meaningful biological information can be extracted from it. The combined hPSC-CM/adult human heart data hence presents a useful resource for evaluating the maturation status of hPSC-CMs at the transcriptional level as well as for assessing cardiac subtype-specific gene expression. Notably, according to our analysis, the frequently used *MYL7* (*MLC2a*) gene appears to be unsuited for discriminating between atrial and ventricular subtypes. Our data instead suggests alternative genes, such as *NPPA* and *NPPB*, as being well-suited markers for evaluating atrial subtype specification in hPSC-CMs.

This work was supported by the Chemical Genomic Centre of the Max Planck Society.

![Biological quality assessment. (A) Scatter plot analysis (power scale) of early hPSC-CMs versus undifferentiated hPSCs (left), late vs. early hPSC-CMs (middle), and 8 week vs. 4 week-old hPSC-CMs (right). Linear correlation coefficients are provided as a measure for global transcriptome similarity. Blue colored dots indicate data points of known marker genes. See text for discussion. (B) *ACTC1* as a pan-cardiac marker is expressed at similar levels in all differentiated in vitro samples (from 1 week onwards). Error bars indicate bead standard deviation extracted from GenomeStudio.](gr1){#f0005}

![Comparison of adult human atrial and ventricular tissue (scatter plot of combined left/right samples). Selected marker genes are highlighted by colored dots. Note that *MYL7* (*MLC2a*) is also highly expressed in ventricular tissue.](gr2){#f0010}

![Comparison of hPSC-CMs and human heart tissue. (A) Global correlation-based dendrogram showing early (1 week-old) and late (combined 4--8 weeks-old) hPSC-CMs clustering closer to human heart (combined atrial and ventricular samples) than to undifferentiated hPSCs. (B) Scatter plots comparing the indicated samples. Examples of genes enriched in the four types of samples are highlighted by different colors (black: hPSCs, blue: early hPSC-CMs, orange: late hPSC-CMs and human heart, red: human heart).](gr3){#f0015}

###### 

Marker genes discriminating between human atrial and ventricular tissue and corresponding expression levels in late (4--8 weeks) hPSC-CMs. P values for differential gene expression are below 0.01 in all cases.

  Symbol                        Atria signal   Ventricles signal   Fold change (V/A or A/V)   hPSC-CMs 4--8 weeks signal   Definition
  ----------------------------- -------------- ------------------- -------------------------- ---------------------------- ---------------------------------------------------------
  *Human ventricular markers*                                                                                              
  DLK1                          5              341                 68                         924                          Delta-like 1 homologue (Drosophila)
  IRX4                          5              204                 41                         252                          Iroquois homeobox 4
  MYL2                          444            18,009              41                         6769                         Myosin, light polypeptide 2, regulatory, cardiac, slow
  XDH                           5              188                 38                         33                           Xanthine dehydrogenase
  TMEM190                       7              255                 37                         46                           Transmembrane protein 190
  HYAL2                         16             532                 34                         112                          Hyaluronoglucosaminidase 2
  CPNE4                         20             650                 32                         Below detection              Copine IV
  CYP1A1                        5              158                 32                         Below detection              cytochrome P450, family 1, subfamily A, Polypeptide 1
  IRX5                          14             387                 27                         42                           Iroquois homeobox protein 5
  C3orf23                       5              112                 22                         24                           Chromosome 3 open reading frame 23
                                                                                                                           
  *Human atrial markers*                                                                                                   
  NPPB                          15,780         19                  824                        2043                         Natriuretic peptide precursor B
  HAMP                          1548           5                   310                        29                           Hepcidin antimicrobial peptide
  MYBPHL                        922            5                   184                        Below detection              Myosin binding protein H-like
  NPPA                          21,892         143                 153                        1615                         Natriuretic peptide precursor A
  PLA2G2A                       478            5                   101                        Below detection              Phospholipase A2, group IIA (platelets, synovial fluid)
  COMP                          396            5                   79                         Below detection              Cartilage oligomeric matrix protein
  TCEAL2                        761            12                  63                         19                           Transcription elongation factor A (SII)-like 2
  SLPI                          274            5                   55                         Below detection              Secretory leukocyte peptidase inhibitor
  DHRS9                         1441           28                  52                         2251                         Dehydrogenase/reductase (SDR family) member 9
  HP                            1316           27                  49                         Below detection              Haptoglobin

###### 

Selected genes enriched in early hPSC-CMs, late hPSC-CMs, and human heart. P values for differential gene expression are below 0.01 in all cases.

  Symbol                                                 hPSCs 0 week signal   hPSC-CMs 1 week signal   hPSC-CMs 4--8 weeks signal   Human heart atr. & ventr. signal   Definition
  ------------------------------------------------------ --------------------- ------------------------ ---------------------------- ---------------------------------- --------------------------------------------------------
  *Genes upregulated in early hPSC-CMs*                                                                                                                                 
  NKX2-5                                                 Below detection       3201                     1549                         583                                NK2 transcription factor related, locus 5
  IRX4                                                   67                    1036                     276                          132                                Iroquois homeobox 4
  TBX2                                                   Below detection       1536                     331                          152                                T-box 2
  COL2A1                                                 20                    694                      39                           Below detection                    Collagen, type II, alpha 1
  ISL1                                                   23                    269                      17                           Below detection                    ISL1 transcription factor, LIM/homeodomain
  HAND1                                                  Below detection       4480                     1231                         632                                heart and neural crest derivatives expressed 1
  ID2                                                    110                   1339                     83                           228                                Inhibitor of DNA binding 2
  LEF1                                                   15                    501                      47                           Below detection                    Lymphoid enhancer-binding factor 1
  IRS1                                                   53                    546                      241                          117                                Insulin receptor substrate 1
  MDK                                                    23                    532                      201                          Below detection                    Midkine (neurite growth-promoting factor 2)
                                                                                                                                                                        
  *Genes upregulated in late hPSC-CMs and human heart*                                                                                                                  
  MYH7                                                   Below detection       938                      11,781                       13101                              Myosin, heavy chain 7, cardiac muscle, beta
  MYL2                                                   Below detection       41                       6838                         7737                               Myosin, light polypeptide 2, regulatory, cardiac, slow
  TNNI3K                                                 below detection       46                       757                          659                                TNNI3 interacting kinase, transcript variant 2
  HSPB7                                                  Below detection       3339                     5428                         5614                               Heat shock 27 kDa protein family, member 7
  PLN                                                    Below detection       1534                     4645                         4638                               Phospholamban
  CSRP3                                                  below detection       540                      1297                         2317                               Cysteine and glycine-rich protein 3
  ACTN2                                                  Below detection       813                      1130                         1739                               Actinin, alpha 2
  RBM20                                                  below detection       440                      1121                         1426                               RNA binding motif protein 20
  TRIM63                                                 Below detection       367                      1116                         1544                               Tripartite motif-containing 63
  CORIN                                                  Below detection       444                      934                          976                                Corin, serine peptidase
                                                                                                                                                                        
  *Genes upregulated in human heart*                                                                                                                                    
  CASQ2                                                  Below detection       10                       23                           6699                               Calsequestrin 2 (cardiac muscle)
  MB                                                     Below detection       727                      633                          12450                              Myoglobin, transcript variant 1
  MYOM2                                                  14                    41                       180                          8272                               Myomesin (M-protein) 2
  TCAP                                                   Below detection       264                      922                          8830                               Titin-cap (telethonin)
  MYH11                                                  below detection       147                      201                          1835                               Myosin, heavy chain 11
  TNNI3                                                  34                    331                      401                          9157                               Troponin I type 3 (cardiac)
  S100A1                                                 Below detection       10                       10                           1482                               S100 calcium binding protein A1
  DES                                                    Below detection       14                       56                           4555                               Desmin
  HRC                                                    24                    1294                     1105                         4976                               Histidine rich calcium binding protein
  MYOM1                                                  Below detection       4787                     4668                         10215                              Myomesin 1, transcript variant
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